Neon Therapeutics, Inc. (NeonT)

Oncology Corporate Profile

HQ Location

215 First Street
Cambridge, MA 2142

Company Description

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allow Neon to develop further treatment modalities including next-generation vaccines and T cell therapies targeting both personalized as well as shared neoantigens.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
NEO-PV-01 (+ nivolumab)neoantigen vaccineBladder cancerIBristol Myers-Squibb
NEO-PV-01 (+ nivolumab)neoantigen vaccineMelanomaI
NEO-PV-01 (+ APX005M)neoantigen vaccineMelanomaIApexigen
NEO-PV-01 (+ nivolumab)neoantigen vaccineNon Small Cell Lung Cancer (NSCLC)I

View additional information on product candidates here »


Recent News Headlines

There are no news items to display